Eric Bjerkholt, CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), bought 2,000 shares at $25.80 ($52K) on 2024-03-18, disclosed to the SEC on 2024-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MIRM | SELL | 2026-07-08 | $611K | — | Filing → |
| CERS | SELL | 2026-06-11 | $53K | — | Filing → |
| MIRM | SELL | 2026-06-09 | $469K | — | Filing → |